| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/09/2008 | EP1906994A2 Airway administration of activated protein c in inflammatory conditions affecting the respiratory tract |
| 04/09/2008 | EP1906993A2 USE OF FACTOR VIIa OR FACTOR VIIa EQUIVALENTS FOR PREVENTING OR ATTENUATING HAEMORRHAGE GROWTH, AND/OR OEDEMA GENERATION FOLLOWING INTRACEREBRAL HAEMORRHAGE (ICH) IN PATIENTS TREATED WITH ANTIPLATELET THERAPY |
| 04/09/2008 | EP1906992A1 Use of a mixture of superoxide dismutase and catalase for treating inflammatory skin lesions |
| 04/09/2008 | EP1906991A2 Use of glp-1 receptor agonists and/or dpp-iv inhibitors in combination with proton pump inhibitors and ppar agonists for the preparation of a medicament for the treatment of diabetes type i, diabetes type ii and impaired pancreatic beta-cell function |
| 04/09/2008 | EP1906989A2 Chaperonin 10-induced immunomodulation |
| 04/09/2008 | EP1906988A2 Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 |
| 04/09/2008 | EP1906987A1 Methods and compositions for emergency contraception using endothelin receptor antagonists |
| 04/09/2008 | EP1906986A1 Lkktet and/or lkktnt peptide compositions which are lyophilized or in a form capable of being lyophilized |
| 04/09/2008 | EP1906985A1 Compositions for administering rnaiii-inhibiting peptides |
| 04/09/2008 | EP1906930A2 Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof |
| 04/09/2008 | EP1906929A2 Biodegradable peptide sustained release compositions containing porogens |
| 04/09/2008 | EP1906923A2 Systems and methods for delivery of a therapeutic agent |
| 04/09/2008 | EP1906918A2 Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders |
| 04/09/2008 | EP1906767A1 Lycopene formulations for the treatment of atherosclerotic conditions |
| 04/09/2008 | EP1824501A4 Protein hydrolysate with antidiabetic effect |
| 04/09/2008 | EP1670919B1 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 04/09/2008 | EP1664123B1 Large scale preparation of alpha-1 proteinase inhibitor and use thereof |
| 04/09/2008 | EP1605957B1 The use of lupin conglutin for the treatment of type ii diabetes |
| 04/09/2008 | EP1572133B1 Method for identifying modulators of human orexin-2 receptor |
| 04/09/2008 | EP1450853A4 Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions |
| 04/09/2008 | EP1394261A4 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 04/09/2008 | EP1360311B1 Membrane penetrating peptides and uses thereof |
| 04/09/2008 | EP1345613B1 Probiotic compounds derived from lactobacillus casei strain ke01 |
| 04/09/2008 | EP1299348B1 Compounds and compositions for delivering active agents |
| 04/09/2008 | EP1280540B1 Modified factor viii |
| 04/09/2008 | EP1228095B1 Modified gp100 and uses thereof |
| 04/09/2008 | EP1227155B1 Process for producing ubiquinone-10 |
| 04/09/2008 | EP1173767B1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 04/09/2008 | EP1140964B1 Connective tissue growth factor (ctgf) fragment |
| 04/09/2008 | EP1058725B1 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 04/09/2008 | EP1036175B1 Human brain derived kcnq2 potassium channel |
| 04/09/2008 | EP1027440B1 Inhibitor protein of the wnt signal pathway |
| 04/09/2008 | EP0972028B1 Mutants of vascular endothelial growth factor c (vegf-c) and uses thereof |
| 04/09/2008 | EP0971958B1 Method for purifying factor viii/vwf complex by cation-exchange chromatography |
| 04/09/2008 | CN101160528A Use of il-17f in diagnosis and therapy of airway inflammation |
| 04/09/2008 | CN101160323A Molecules and methods of using same for treating mcp-1/ccr2 associated diseases |
| 04/09/2008 | CN101160322A Molecules and chimeric molecules thereof |
| 04/09/2008 | CN101160321A Q3 sparc deletion mutant and uses thereof |
| 04/09/2008 | CN101160319A Polymyxin b analogs for lps detoxification |
| 04/09/2008 | CN101160318A Compositions and methods for topical application and transdermal delivery of an oligopeptide |
| 04/09/2008 | CN101160139A Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing PEDF and FGF2 |
| 04/09/2008 | CN101160123A Combinations and modes of administration of therapeutic agents and combination therapy |
| 04/09/2008 | CN101160117A Apparatus and method for transdermal delivery of epoetin-based agents |
| 04/09/2008 | CN101157924A Neutrophil leukocyte gene alpha |
| 04/09/2008 | CN101157730A Fusion protein penetrating blood-brain barrier with nerve nourishment gene and encoding gene and uses thereof |
| 04/09/2008 | CN101157729A Tumour putrescence gene related apoptosis ligand variant and uses thereof |
| 04/09/2008 | CN101157726A Deuterohemin short-peptide compound and its application in preparation of anti-cataractogenesis drugs |
| 04/09/2008 | CN101157725A Preparation method of human insulin analogue and usage thereof |
| 04/09/2008 | CN101157724A Modified recombinant porcine alpha interferon protein and coding gene and uses thereof |
| 04/09/2008 | CN101157720A Template fixed peptide analogue as serine protease inhibitor |
| 04/09/2008 | CN101156948A Non neurotoxicity plasminogen incitant for treating palsy |
| 04/09/2008 | CN101156947A Ginseng source peptide albumen, its preparing method and application |
| 04/09/2008 | CN101156946A Application of antihypelipidemic medicine, hydrochloric acid racemic anisodamine, vitamine B**, nerve growth factor in the preparation of combination medicine for treating diabetes |
| 04/09/2008 | CN101156945A Unitary combinations of FSH and hCG |
| 04/09/2008 | CN101156944A Cleavage liquid for preventing and curing nervus energy disease scathing nervus stem cell |
| 04/09/2008 | CN101156943A Secreted neural apoptosis inhibiting proteins |
| 04/09/2008 | CN101156942A Medicine combination for treating relapse stomatocace and chronic pharyngitis |
| 04/09/2008 | CN101156872A Compound recipe bone-peptide preparation |
| 04/09/2008 | CN101156836A A method for forming dextran 40/ polypeptide freeze dried powder injection solution |
| 04/09/2008 | CN100379881C Skin treatment |
| 04/09/2008 | CN100379869C Super antigen fusion protein and its application method |
| 04/09/2008 | CN100379865C Method and reagents for vaccination which generate a CD8 T cell immune response |
| 04/09/2008 | CN100379855C Monkey monoclonal antibodies specific to human b. 7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 04/09/2008 | CN100379762C Interfusion protein between human serum albumin and interleukin, and encoding genes |
| 04/09/2008 | CN100379760C Peptides and compounds that bind to receptor |
| 04/09/2008 | CN100379759C Compounds for treatment of infectious and immune system disorders and method for their use |
| 04/09/2008 | CN100379758C Streptococcus pneumoniae antigens |
| 04/09/2008 | CN100379756C Polyamid-oligonucleotide derivative, preparation and application of same |
| 04/09/2008 | CN100379752C Antagonists of BMP and TGF beta signalling pathway |
| 04/09/2008 | CN100379751C Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 04/09/2008 | CN100379722C New compounds |
| 04/09/2008 | CN100379449C Compositions of SOD and vetetative medicine or its extractives, and its preparation method |
| 04/09/2008 | CN100379448C 蛋白酶抑制剂 Protease inhibitors |
| 04/09/2008 | CN100379447C Composition containing PVA-124 and its application |
| 04/09/2008 | CN100379446C Erythropoietin ameliorates chemotheapy-induced toxicity in vivo |
| 04/09/2008 | CN100379424C Calcium phosphate delivery vehicles for osteoinductive proteins |
| 04/09/2008 | CN100379412C Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia |
| 04/08/2008 | US7355056 Transferring agent into cells; using polypeptides, polynucleotides, antibodies nucleic acids ; tumor suppressor gene; anticancer agents |
| 04/08/2008 | US7355035 Catalytic molecules |
| 04/08/2008 | US7355025 Marker molecules associated with lung tumors |
| 04/08/2008 | US7355024 Regulatory sequences for modulation of INGAP expression and reporter constructs |
| 04/08/2008 | US7355019 Cysteine-containing peptide tag for site-specific conjugation of proteins |
| 04/08/2008 | US7355018 human insulin-like growth factor-1 fusion polypeptide that includes a component capable of forming a multimer with another modified IGF-1 fusion polypeptide; useful for treating a muscle-related disease or condition, such as muscle atrophy |
| 04/08/2008 | US7355017 Fusion polypeptide for use in the treatment and prevention of graft rejection |
| 04/08/2008 | US7355016 Methods for detection of mycobacteria |
| 04/08/2008 | US7355015 Matriptase, a serine protease and its applications |
| 04/08/2008 | US7355014 Monoclonal antibody used to purify the interferon-gamma inducing polypeptide; antitumor agents |
| 04/08/2008 | US7355011 Comprises chimeric antibodies for diagnosis and treatment of lymphomas; antitumor agents |
| 04/08/2008 | US7355007 Antibodies that bind PRO5005 Polypeptides |
| 04/08/2008 | US7355006 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/08/2008 | US7355005 Recombinant chimeric Transmembrane Activator and Calcium-Signal Modulating Cyclophilin Ligand-Interactor protein that functions as a cell surface signaling protein; can thus be targeted to specifically regulate B cell responses without affecting mature T cell activity; autoimmune diseases |
| 04/08/2008 | US7355001 Diagnostic marker for diseases associated with the liver, pancreas , immunological system (thymus failure), reproduction, digestive system, skin, central nervous system, spleen, respiratory system, and thyroid hormone, and diabetes, hypertension, cancer, reperfusion injury following ischemia, retinitis |
| 04/08/2008 | US7354999 PRO1481 polypeptides |
| 04/08/2008 | US7354998 PRO7171 polypeptides |
| 04/08/2008 | US7354996 Solubilizing a protein in urea or guanidine HCl as a denaturing agent, modification with o-nitrobenzenesulfenyl chloride, mixing protein with a similarly modified control protein, resolubilizing, reducing and alkylating, trypsin digestion, separating modified peptide fragments, mass spectrometrometry |
| 04/08/2008 | US7354994 Recombinant IGF expression systems |
| 04/08/2008 | US7354923 Piperazine melanocortin-specific compounds |
| 04/08/2008 | US7354908 Materials and methods for prevention and treatment of RNA viral diseases |
| 04/08/2008 | US7354905 Thrombosis therapy; anticoagulants |
| 04/08/2008 | US7354904 Bacteriocin inducer peptides |